![](https://s44650.pcdn.co/wp-content/uploads/2023/10/GF-logo-reworked-Colour-Square-768x768.jpg)
News
Can New CEO End Crisis For Teva Pharmaceutical
Kåre Schultz willtake over as CEO at a time when the pharmaceutical companystruggles withcompetition, downwardpressure on drug prices,expiring patents, risingoperational costs, bribery investigations,fines and failed acquisitions.